| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Medical Departments M (Endocrinology and Diabetes) (C.N., L.C.G., N.J., N.M., S.L., J.O.L.J.) and C (S.B.P.), Aarhus University Hospital, DK-8000 Aarhus C, Denmark
Address all correspondence and requests for reprints to: Charlotte Nielsen, Medical Department M, Aarhus University Hospital, Norrebrogade 44, DK-8000 Aarhus C, Denmark. E-mail: lolle{at}sol.dk.
Context: GH induces insulin resistance in muscle and fat, and in vitro data indicate that this may involve cross-talk between the signaling pathways of the two hormones.
Objective: Our objective was to investigate GH and insulin signaling in vivo in human muscle and fat tissue in response to GH, GH receptor blockade, and insulin stimulation.
Design: We conducted two randomized crossover studies.
Participants: Sixteen healthy males participated.
Intervention: GH was administered as a bolus (n = 8) and constant infusion (n = 8). The bolus study included three arms: 1) control (saline), 2) GH (0.5 mg iv), and 3) GH blockade (pegvisomant 30 mg sc), each combined with a hyperinsulinemic glucose clamp. The infusion study included two arms: 1) GH infusion (45 ng/·kg·min, 5.5 h) and 2) saline infusion (5.5 h) combined with a hyperinsulinemic glucose clamp during the final 2.5 h.
Main Outcome Measures: Muscle and fat biopsies were subjected to Western blotting for expression of Stat5/p-Stat5, Akt/p-Akt, and ERK1/2/p-ERK1/2 and to real-time RT-PCR for expression of SOCS1–3 and IGF-I mRNA.
Results: GH significantly reduced insulin sensitivity. The GH bolus as well as GH infusion induced phosphorylation of Stat5 in muscle and fat, and SOCS3 and IGF-I mRNA expression increased after GH infusion. Hyperinsulinemia induced Akt phosphorylation in both tissues, irrespective of GH status. In muscle, ERK1/2 phosphorylation was increased by insulin, but insulin per se did not induce phosphorylation of Stat5.
Conclusions: GH exposure associated with insulin resistance acutely translates into GH receptor signaling in human muscle and fat without evidence of cross-talk with insulin signaling pathways. The molecular mechanisms subserving GH-induced insulin resistance in humans remain unclarified.
This article has been cited by other articles:
![]() |
N. Moller, L. C. Gormsen, O. Schmitz, S. Lund, J. O. L. Jorgensen, and N. Jessen Free Fatty Acids Inhibit Growth Hormone/Signal Transducer and Activator of Transcription-5 Signaling in Human Muscle: A Potential Feedback Mechanism J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2204 - 2207. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. de Castro Barbosa, J. E. Nicoletti de Carvalho, L. Lourenco Poyares, S. Bordin, U. Fabres Machado, and M. T. Nunes Potential Role of Growth Hormone in Impairment of Insulin Signaling in Skeletal Muscle, Adipose Tissue, and Liver of Rats Chronically Treated with Arginine Endocrinology, May 1, 2009; 150(5): 2080 - 2086. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Moller and J. O. L. Jorgensen Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects Endocr. Rev., April 1, 2009; 30(2): 152 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Salgin, M. L. Marcovecchio, S. M. Humphreys, N. Hill, L. J. Chassin, D. J. Lunn, R. Hovorka, and D. B. Dunger Effects of prolonged fasting and sustained lipolysis on insulin secretion and insulin sensitivity in normal subjects Am J Physiol Endocrinol Metab, March 1, 2009; 296(3): E454 - E461. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |